Gvither Injection (Artemether 80mg/1ml)
Product Description
Gvither Injection contains 80mg of Artemether per 1ml and is used for the treatment of acute uncomplicated or severe malaria caused by Plasmodium falciparum. Artemether is a potent, fast-acting antimalarial agent from the artemisinin class that rapidly reduces parasite load in the bloodstream.
This injectable formulation is especially useful in situations where oral therapy is not possible or when rapid parasite clearance is required. Gvither is typically administered via intramuscular (IM) injection under the supervision of a qualified healthcare provider.
Key Features
- Contains Artemether 80mg per 1ml ampoule
- Rapid onset of action for malaria crisis management
- Suitable for intramuscular administration
- Effective against drug-resistant Plasmodium falciparum
- Used as part of initial emergency treatment followed by oral antimalarial therapy
Indications
- Treatment of severe or resistant malaria infections
- Management of malaria in patients unable to take oral medication
- Initial therapy in high-transmission or emergency settings
Directions for Use
- For intramuscular use only by trained healthcare professionals
- Dosage based on patient’s body weight and clinical status
- Typically administered once daily for 3 days, followed by completion with an oral ACT (artemisinin-based combination therapy)
- Do not use unless solution is clear and vial is intact
Precautions
- Strictly for parenteral use; not to be administered orally or intravenously
- Use with caution in patients with liver or kidney impairment
- Not recommended during the first trimester of pregnancy unless clearly necessary
- Monitor for possible neurotoxicity or allergic reactions during therapy